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A new strategy for creating functional tri-layer nanofibers through triaxial
electrospinning is demonstrated. Ethyl cellulose (EC) was used as the
filament-forming matrix in the outer, middle, and inner working solutions, and was
combined with varied contents of the model active ingredient ketoprofen (KET) in the
three fluids. Triaxial electrospinning was successfully carried out to generate
medicated nanofibers. The resultant nanofibers had diameters of 0.74 ± 0.06 µm,
linear morphologies, smooth surfaces, and clear tri-layer nanostructures. The KET
concentration in each layer gradually increased from the outer to the inner layer. In
vitro dissolution tests demonstrated that the nanofibers could provide linear release of
KET over 20 h. The protocol reported in this study thus provides a facile approach to
creating functional nanofibers with sophisticated structural features.
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3INTRODUCTION
The traditional practice of repeated oral administration of high doses of a drug at
frequent time points is highly undesirable because of the risk of adverse side effects
and also because of potential issues with patient compliance. As a result, controlled
and sustained release drug delivery systems (DDSs) have attracted enormous amounts
of research effort. 1-3 The primary method used to achieve sustained-release profiles
involves the combination of active ingredients with polymeric excipients.1,4
In terms of the administration route, oral delivery is most widely explored
because it facilitates high levels of patient compliance. However, a frequent concern
associated with oral sustained-release DDS is their predisposition to an initial “burst”
of drug release; this is particularly common and problematic in nanoscale DDS.1 One
nanoscale system which has attracted much attention comprises electrospun
nanofibers, which are fabricated by using electrical energy to evaporate the solvent
rapidly from a mixed solution containing an active ingredient and a filament-forming
polymer. 5–7 The large surface area, high porosity, and commonly amorphous physical
state of drugs loaded in such fibers make them very promising for the development of
fast disintegrating DDS and effective delivery of poorly water-soluble drugs, whose
formulation development remains one of the most intractable challenges in
pharmaceutics.6 The formation of a solid solution or suspension means that there is no
lattice energy barrier to dissolution (cf. a typical crystalline active ingredient), thereby
increasing both dissolution rate and solubility in favorable instances. Unfortunately,
these characteristics endow the fibers with poor performance in terms of
4sustained-release, owing to their usually exhibiting an uncontrollable and undesirable
initial burst of release. 7
To overcome this issue, coaxial electrospinning and modified coaxial
electrospinning have been investigated to prepare core-sheath nanofibers with a blank
(drug-free) sheath to eliminate this initial burst release.5,7,9 Moving forward, a much
sought-after class of DDS offers linear or zero-order release, because such systems
can maintain the drug concentrations in a specified therapeutic window for a
prolonged period of time after administration.10 This results in high levels of patient
compliance, and minimal side effects.
Over the past two decades, great advances in multiple-fluid electrospinning have
been achieved; this technique can create polymeric nanofibers, generate
nanofiber-based composites, and produce nanofiber-based hybrids embedded with
functional micro- or nanoparticles, and even cells11-15 (Figure 1). Large-scale
production of electrospun nanofibers from a single-fluid has been proved to be
eminently possible, and industrial systems allowing this now exist.16-18 However, the
creation of complicated nanostructures from templates at the macro-scale in a
“top-down” manner (i.e., using the structural characteristics of the spinneret to
produce nanostructures with analogous features), has yet to be fully explored.19 The
creation of core-sheath nanostructures using a concentric spinneret has been widely
reported, but there is a deficit of knowledge regarding other more complex structure
types.20-23 There are very few investigations into side-by-side electrospinning to
generate Janus nanofibers, 24-29 and even fewer reports on multiple-layer nanofibers.
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The slow development of multiple-fluid electrospinning processes is related to
their difficulty of implementation. The successful preparation of multi-component
fibers requires the spinning fluids to have good compatibility, so that they can be
drawn together by electrical forces without any coagulation. It is also necessary that
the fluids have similar physicochemical properties, such that they experience similar
electrical drawing forces. If one of the fluids dries faster than the others, undesirable
phenomena such as the separation of fluids may occur. The more similar the working
fluids are, the more successful multiple-fluid electrospinning tends to be.
Figure 1. Development of the electrospinning process. “A” represents complicated nanostructures
with side-by-side and core-sheath structures.
Medicated nanofibers for biomedical applications are typically prepared by the
addition of functional ingredients to the spinning solution. The functional moieties
frequently have little influence on the electrospinnability of the working fluids.
Triaxial electrospinning can thus be performed to create tri-layer nanofibers in which
each layer is based on the same polymer matrix, but with different functional
components or compositions. Using this concept, a tri-axial electrospinning process in
which all three working fluids contained the same polymer (ethyl cellulose; EC), but
6different drug contents, was developed. This permitted us to create a new type of
medicated nanofibers with gradient distributions of the active ingredient. The resultant
nanofibers were characterized, and their drug release profiles quantified.
EXRIMENTAL SECTION
Materials. Ethyl cellulose (EC, 6–9 mPa·s) was obtained from the Shandong Ruitai
Chemical Corporation (Feicheng, China). KET was purchased from the Shanghai
Wanjiang Biological Technology Co., Ltd. (Shanghai, China). Anhydrous ethanol,
methylene blue, and basic fuchsin were purchased from the Shanghai Chemical
Reagent Company (Shanghai, China). All other chemicals used were of analytical
grade, and water was doubly distilled before use.
Electrospinning. The tri-layer concentric spinneret was homemade. Three syringe
pumps (KDS100, Cole-Parmer, Vernon Hills, IL, USA) and a high-voltage power
supply (ZGF 60kV/2 mA, Shanghai Sute Corp., Shanghai, China) were used for
electrospinning. The collector comprised a flat piece of cardboard wrapped with
aluminum foil. All electrospinning processes were carried out under ambient
conditions (21 ± 5 °C with a relative humidity of 49% ± 7%). The electrospinning
process was recorded using a digital camera (PowerShot A490, Canon, Tokyo, Japan).
After optimization, the applied voltage and spinneret-to-collector distance were fixed
at 12 kV and 15 cm, respectively.
To facilitate observation of the electrospinning processes, 1×10-5 mg/mL of
methylene blue was added to the inner fluid and 5×10-6 mg/mL basic fuchsin to the
7middle fluid.
Morphology. The morphology of the fibers was investigated using a Quanta FEG450
field emission scanning electron microscope (FESEM; FEI Corporation, Hillsboro,
OR, USA). Prior to examination, samples were sputter-coated with gold under a
nitrogen atmosphere to render them electrically conductive. Images were recorded at
an excitation voltage of 20 kV. The average fiber size was determined by measuring
the diameters of the fibers at over 100 points in FESEM images, using the NIH
ImageJ software (National Institutes of Health, Bethesda, MD, USA). To view their
cross sections, fibers were placed in liquid nitrogen and manually broken before gold
coating.
TEM images of the samples were recorded on a JEM 2100F field emission TEM
(JEOL, Tokyo, Japan). Samples were obtained by fixing a lacey carbon-coated copper
grid on the collector and electrospinning directly onto the grid for several minutes.
Physical form and compatibility. X-ray diffraction (XRD) was conducted over the
2θ range from 5° to 60° using a D/Max-BR diffractometer (Rigaku, Tokyo, Japan)
with Cu Kα radiation at 40 kV and 30 mA. DSC was conducted using an MDSC 2910
differential scanning calorimeter (TA Instruments Co., New Castle, DE, USA).
Samples were heated at a rate of 10 °C/min from 20 °C to 250 °C under a 40 mL/min
flow of nitrogen. Attenuated total reflectance-Fourier transform infrared (ATR-FTIR)
spectroscopy was carried out on a Nicolet-Nexus 670 FTIR spectrometer (Nicolet
Instrument Corporation, Madison, USA) over the range of 500–4000 cm–1 at a
resolution of 2 cm−1.
8Drug content and in vitro dissolution tests. The total drug content was determined
according to the following procedure: exactly 0.1 g of the fibers was placed into 10
mL ethanol to free the loaded KET. After complete dissolution, 1.0 mL of the ethanol
solution was dropped into 100 mL of physiological saline (PS, 0.9 wt.%) under
agitation. Aliquots of the aqueous solutions were filtered using a 0.22 µm membrane
(Millipore, Billerica, MA, USA) before quantification using a UV-visible
spectrophotometer (UV-2102PL, Unico Instrument Co. Ltd., Shanghai, China).
In vitro dissolution tests were carried out according to the Chinese
Pharmacopoeia (2010 Edn.). Method II, which is a paddle method, was undertaken
using a RCZ-8A dissolution apparatus (Tianjin University Radio Factory, Tianjin,
China). 0.2 g of the sample was placed in 600 mL of PS (37 ± 1 °C). The instrument
was set to stir at 50 rpm, and sink conditions with C < 0.2Cs were maintained. At
predetermined time points, 5.0 mL aliquots were withdrawn from the dissolution
medium and replaced with fresh medium to maintain a constant volume. After
filtration through a 0.22 µm membrane and appropriate dilution with PS, samples
were analyzed at λmax = 260 nm. The amount of KET released was back calculated
from the data obtained against a predetermined calibration curve. Experiments were
performed six times, and results are reported as mean ± S.D.
RESULTS AND DISCUSSION
A diagram illustrating the triaxial electrospinning process is shown in Figure 2.
As for single-fluid electrospinning, the triaxial electrospinning system is composed of
9four components: three syringe pumps to drive the three working fluids, a
high-voltage power supply, a grounded fiber collector, and a tri-layer concentric
spinneret.
Figure 2. A schematic of the triaxial electrospinning process.
The key to successful triaxial electrospinning is ensuring that the inner, middle,
and outer laminar fluids form a compound the Taylor cone, and stay together in a
concentric manner throughout the electrospinning process. The physicochemical
properties of a fluid, such as surface tension, conductivity, and viscoelasticity,
determine its behavior under a high-voltage electrostatic field. Thus, in this work,
very similar polymer solutions (23% w/v EC in ethanol, Table 1) with varied
ketoprofen (KET) concentrations were employed as working fluids. These solutions
are anticipated to endow the three fluids with the highest compatibility and ensure
similar behaviors under the electrical field.
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Table 1. The preparation of fibers with gradient distributions of KET in EC
Layer










(w/w%) The overall drug
content in the fibers
is 10.78% (w/w)
Outer 23 1 2 4.17 95.83
Middle 23 5 0.5 17.86 82.14
Inner 23 15 0.2 39.47 60.53
a Cf-KET and Cf-EC refer to KET and EC concentrations in the working fluids.
b CKET and CEC refer to the theoretical contents of KET and EC in the different layers of the
nanofibers.
The design of the spinneret is of critical importance in ensuring a robust and
reproducible electrospinning process.36,37 A well-designed spinneret not only provides
a suitable template for producing the desired nanofiber architectures but can also
allow behavioral control of the fluids under an electrical field. The tri-layer spinneret
used in this work is depicted in Figure 3. It consists of three concentric metal
capillaries; the inner capillary has an outer diameter (Do) of 0.4 mm and an inner
diameter (Di) of 0.20 mm, the middle capillary has Do of 1.1 mm and Di of 0.9 mm,
and the outer capillary has Do of 1.8 mm and Di of 1.5 mm. All are made from
austenitic stainless steel (O6Cr19Ni10, GB24511, China). The end of the middle
capillary projects 0.2 mm over the inner capillary, and the outer capillary similarly
projects 0.2 mm over the middle capillary (upper-left inset of Figure 3). This structure
is expected to promote encapsulation of the inner fluid by the middle fluid and, in turn,
the middle by the outer fluid, as well as inhibiting diffusion among the fluids after
ejection from the capillary nozzles.
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Figure 3. Digital photographs of the triaxial electrospinning process. The upper-left insets show
the structure of the homemade spinneret, and the upper-right inset a typical compound Taylor
cone.
Figure 3 shows a typical triaxial electrospinning process. A compound Taylor
cone is clearly visible, from which a straight fluid jet is emitted. This is followed by
an unstable region with bending and whipping loops. The three layers of the Taylor
cone can be clearly discerned, as the inner and middle fluids are colored blue and pink
as a result of the inclusion of methylene blue and basic fuchsin (upper-right inset of
Figure 3). The connections of the spinneret to the power supply and syringe pumps
are depicted in the Supporting Information. An ethanolic solution with an EC
concentration of 23% (w/v) shows good electrospinnability,38,39 and, given the
similarity of the three working solutions, the tri-axial electrospinning process can be
performed continuously and smoothly without any clogging or other adverse
phenomena arising.
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Figure 4. FESEM images of the tri-layer fibers: (a) and (b) Surface morphology and size
distribution and (c) and (d) cross-sectional morphology. The lower left inset to (d) shows an
occasional instance where different layers can be observed in the cross-section.
All three working fluids were individually electrospinnable and could be
processed using single-fluid electrospinning process. Details of these nanofibers are
found in the Supporting Information. FESEM images of the tri-layer nanofibers
resulting from triaxial electrospinning and their size distributions are given in Figures
4a and 4b. The tri-layer fibers have bead-free linear morphologies and smooth
surfaces with an average diameter of 0.74 ± 0.06 µm. A sample of the fibers was
manually broken to examine their internal cross sections (Figures 4c and 4d). These
mainly appear smooth, although occasional irregular cross sections may also be found,
as depicted in the lower left inset of Figure 4d. In such cases, the fibers may have
broken such that the different layers can be discerned. Although addition of KET has
little influence on the electrospinnability of the working fluids, its presence and
content can influence the mechanical properties of different layers,40 thereby resulting
in an uneven surface after breaking.
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Figure 5. A TEM image of a tri-layer nanofiber.
Figure 5 depicts a transmission electron microscope image of one of the fibers,
which exhibits a clear tri-layer structure with the inner layer showing a very dark gray
color and the outer layer showing a light gray color; these differences in color are
attributed to the different drug contents of the layers. Diffusion of KET molecules
from one layer to another is expected to be minimal because of the parallel flow of
different fluids and rapid drying of the layers during electrospinning.41
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Figure 6. Characterization of the raw materials and the KET-loaded fibers: (a) XRD patterns, (b)
DSC thermograms, and (c) IR spectra and chemical structures of KET and EC.
The presence of a large number of distinct reflections in the X-ray diffraction
(XRD) pattern of KET (Figure 6a) confirms that the drug is a crystalline material. The
diffraction pattern of EC exhibits a diffuse background pattern with two diffraction
halos, which is to be expected since it is known to be amorphous. In the XRD pattern
of the tri-layer nanofibers no characteristic KET reflections are visible, which
demonstrates that KET is no longer present as a crystalline material in the fibers and
has been converted into an amorphous state within the polymer matrix in all three
layers. The differential scanning calorimetry (DSC) thermograms in Figure 6b concur
with the XRD results. KET displays a distinct melting endothermic peak at 95.9 °C
(ΔHf = –115.1 J/g); in contrast, no melting events can be seen in the traces of EC and
the tri-layer nanofibers.
KET molecules possess carbonyl groups (potential proton receptors), whereas
EC molecules have free hydroxyl groups (potential proton donors for hydrogen
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bonding; Figure 6c). Thus, hydrogen bonding may occur in the fibers, and is
confirmed by their IR spectrum. Here, the characteristic peaks of pure KET at 1697
and 1658 cm–1 (attributed to the vibrations of carbonyl groups) cannot be observed.
Other secondary interactions, such as hydrophobic interactions between the benzene
rings and the carbon chains of EC, may also play a role in the formation of EC-KET
nanocomposites.
KET has λmax = 260 nm, and thus a calibration curve was constructed at this
wavelength: C = 14.96 A-0.0013 (R = 0.9999), where C is the KET concentration
(μg/mL) and A is the solution absorbance at 260 nm (linear range: 2–20 μg/mL). The 
measured KET loading in the fibers was 108.1 ± 3.4 mg/g (n = 3), almost equivalent
to the theoretically calculated value of 107.8 mg/g.
Monolithic nanofibers prepared individually from each of the three working
solutions using single-fluid electrospinning have similar drug release profiles. An
initial burst release is followed by a slowing in the release rate (Figure 7a, other
details may be found in the Supporting Information). In sharp contrast, the three-layer
nanofibers were able to provide zero-order KET release for over 20 h with a best-fit
equation of Q = 1.73+4.24t (R2 = 0.9972), where Q is the drug release percentage, t is
the release time, and R is the correlation coefficient (Figure 7b). The initial burst
release and the slow-down at the end of the dissolution process are negative
phenomena that inevitably arise with monolithic drug-loaded nanofibers (and also
many traditional sustained-release DDS).42,43 No burst release was observed from the
tri-axial nanofibers, and the drug was released at a constant rate for nearly one day.
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EC is insoluble in water, and thus the drug release is expected to arise form diffusion
of the drug out of the fibers and into the dissolution milieu. FESEM images of the
tri-layer nanofibers after complete KET release are included in Figures 7c and 7d. The
surfaces and cross sections of the tri-layer nanofibers are wrinkled, which indicates
they may have collapsed following the formation of voids when KET is freed into
solution.
Figure 7. (a) and (b) In vitro dissolution test results of the monolithic nanofibers and the tri-layer
nanofibers, (c) and (d) FESEM images of the tri-layer nanofibers after release of all the KET
loading, and (e) a diagram explaining how the gradient drug distribution can yield a linear release
profile.
The surface area of the middle layer of the fibers is smaller than that of the
outermost layer, and the inner layer has a still smaller surface area (Si<Sm<So; see
Figure 7e). In addition, the distances through which the drug molecules must diffuse
to reach the dissolution medium gradually increase going from the exterior to the
interior of the fibers (Ri>Rm>Ro; Figure 7e). These factors would normally result in
an initial burst release because of the large surface area at the outermost layer and the
short distance through which escaping drug molecules must diffuse. However, by
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gradually increasing the drug concentrations in the middle and inner layers, the effects
of surface area and diffusion distance on the sustained-release profile of the
nanofibers can be counteracted, resulting in the desired linear release profile.
CONCLUSIONS AND PERSPECTIVES
The facile preparation of tri-layer nanofibers using a triaxial electrospinning
process was successfully demonstrated in this work. Triaxial electrospinning could be
continuously and smoothly performed using inner, middle, and outer working fluids
containing the same concentration of EC but varied concentrations of the functional
ingredient KET. These fluids were highly compatible and behaved similarly under the
electric field. The resultant fibers were structural nanocomposites with a linear
morphology, smooth surfaces, and clear three-layer structures. The content of KET
was designed to incrementally increase moving from the exterior of the fibers inwards,
resulting in a gradient distribution of the drug. This led to a system able to provide
zero-order release for over 20 h. By incorporating this formulation into an
enteric-coated capsule, a linear release colon-targeted oral drug delivery system can
be produced.
This study developed an advanced functional nanomaterial using a tri-axial
electrospinning process and solutions of the same filament-forming polymer matrix
for all three working fluids. A range of different types of functional materials and
electrospinning processes can be generated from this simple procedure. Several
examples include:
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(1) Incorporation of different ingredients in the layers of the tri-layer fibers for
multi-functional materials. Different functional ingredients or even inorganic
nanoparticles could be encapsulated into the different layers of the fibers for a
combined action, synergistic action, or to exert multiple functions. Such
multifunctional fiber mats might find important applications as scaffolds in tissue
engineering.44,45
(2) New tri-layer templates for creating structural inorganic products and
manipulating molecular self-assembly. Electrospun nanofibers are often indirectly
used as templates for creating inorganic nanofibers, nanotubes, or carbon nanofibers.
A wide variety of functional inorganic nanofibers (containing for instance metallic
oxides and metals), nanotubes, and carbon nanofibers with varied components and
compositions could be generated by loading different materials in the layers of the
fibers.
(3) New triaxial electrospinning processes. New types of triaxial electrospinning
processes can be further developed through careful consideration of the compatibility
between working solutions. For instance, our method could be used to develop
gas-assisted melt triaxial electrospinning, wherein an auxiliary gas flows through the
outer capillary, similar to gas-assisted melt co-axial electrospinning.46 Solvents,
solutions of small molecules, or unspinnable diluted polymer solutions can be used as
outer fluids to yield a series of modified triaxial electrospun products, similar to those
which have been generated using modified coaxial electrospinning.47-49
(4) Implementation of other types of multiple-fluid electrospinning for creating
19
complicated functional nanostructures. Many other types of complicated
nanostructures, such as side-by-side or combinations of side-by-side and core-sheath
materials, may also be obtained (Figure 1).
SUPPORTING INFORMATION
Details of the connection of the tri-layer concentric spinneret to the power supply and
syringe pumps; FESEM images of the monolithic nanofibers fabricated from the outer
fluid, the middle fluid, and the inner fluid individually using single-fluid
electrospinning processes; mathematical calculations employed to determine the
mechanism of drug release from the monolithic fibers. This material is available free
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